MARKET WIRECNBC • 1h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Why CODX Stock dropped -10.49% Today — RQD Quant Desk Flash
$0.40 -10.49% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
Co-Diagnostics Inc. (CODX) carries a Roarable Rating of D- (Sell) with 37/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D- • RED ALERT
Cap $3.5M
INTERACTIVE SCENARIO DECK:
RQD QUANT TACHOMETERRED ALERT • D-
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D- · Rk D-
Each axis scored 0–20
12M PRICE TARGET CONE-10% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CODX)Realized 20D OHLCV Swing Band: ±12.5%
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why CODX Stock dropped -10.49% Today — RQD Quant Desk Flash
Co-Diagnostics Inc. (CODX) dropped -10.49% to $0.40, trading at 2% of its 52-week range ($0.37 – $13.8). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 2% of its 52-week range ($0.37 – $13.8) with RSI-14 at 19.1 (OVERSOLD (<32)).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $0.40 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 40% gross margin and $0 annual free cash flow.
Live CODX Headlines & Catalysts
MARKET WIRECNBC • 2h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 3h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 4h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 5h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 6h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 6h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
MARKET WIREReuters • 6h ago
German ministers pledge tough action after rioters damage stores in Frankfurt - ReutersGerman ministers pledge tough action after rioters damage stores in Frankfurt Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring CODX)
- ✓Walkthrough of CODX's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
CODX // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -74.19%⚡ TESTING RESISTANCE
2026-10-30O $0.40H $0.40L $0.37C $0.40VOL 233.3K
RES: $0.65SUP: $-2.52SMA50: $0.98SMA200: $2.20
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
CODX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. -65.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on CODX today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for CODX. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for CODX today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CODX)
Health Care Rank #769 of 1016
⚔️ ICCM vs CODX Full Matrix →
1. Head-to-Head Health Care Peer Comparison (CODX vs. ICCM, XAIR, AMIX, NVNO)
Industry: Medical/Dental Instruments (120 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Co-Diagnostics Inc. (CODX) ranks #769 by composite RQD confidence (37/100, grade D-) and #970 by equity capitalization ($3.5M). Within this direct 5-issuer industry benchmark cohort, XAIR leads on earnings valuation at 112.1x trailing P/E, while CODX leads on capital efficiency and profitability with -35.0% ROIC and 64.3% gross margin. NVNO currently holds the highest overall quantitative score in the immediate peer group at 50/100 (D) compared with CODX at 37/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| CODX
ACTIVE
Co-Diagnostics Inc. | D- | 37/100 | — | 64.3% | -35.0% | -10.49% | $3.5M | Benchmark Subject |
| ICCM IceCure Medical Ltd. | D | 46/100 | — | 36.3% | -35.0% | -2.13% | $3.3M | /iccm-vs-codx → |
| XAIR Beyond Air Inc. | D- | 42/100 | 112.1x | 3.3% | -35.0% | -2.12% | $3.8M | /xair-vs-codx → |
| AMIX Autonomix Medical Inc. | D- | 37/100 | — | — | -35.0% | -5.12% | $4.0M | /amix-vs-codx → |
| NVNO enVVeno Medical Corporation | D | 50/100 | — | — | -35.0% | +4.08% | $4.9M | /nvno-vs-codx → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001692415In its most recent audited fiscal period (FY2025, filed 2025-12-31), Co-Diagnostics Inc. (CODX) reported GAAP revenue of $622.5K (-84.1% vs. FY2024 revenue of $3.9M , and -90.9% cumulative change since FY2023) , GAAP net income of -$47.0M, operating cash flow of -$29.1M, and free cash flow of -$29.8M (+0.2% YoY). On the balance sheet, CODX closed FY2025 with $24.7M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 3/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $622.5K | -$47.0M | -$29.1M | -$29.8M | $24.7M | — |
| FY2024 (FY) | 2024-12-31 | $3.9M | -$38.0M | -$29.2M | -$29.9M | $63.6M | — |
| FY2023 (FY) | 2023-12-31 | $6.8M | -$35.3M | -$22.1M | -$22.1M | — | — |
3. CODX Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs CODX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Co-Diagnostics Inc. (NASDAQ: CODX) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 37/100 at a spot price of $0.40 (-10.49% 1D, market cap $3.5M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, CODX ranks #769 in composite RQD confidence.
How does CODX compare to ICCM and XAIR in the Health Care sector?
Within the Health Care sector (Medical/Dental Instruments), CODX carries a Roarable D- (37/100 RQD), trailing P/E of N/A, gross margin of 64.3%, and ROIC of -35.0%. By comparison, ICCM (IceCure Medical Ltd.) holds a D grade (46/100 RQD, P/E N/A, ROIC -35.0%, cap $3.3M) and XAIR (Beyond Air Inc.) posts a D- grade (42/100 RQD, P/E 112.1x, ROIC -35.0%, cap $3.8M). Among the 5-stock peer group, XAIR leads on earnings multiple (112.1x) while CODX leads on capital efficiency (-35.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for CODX?
Per CODX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001692415), Co-Diagnostics Inc. generated $622.5K in revenue (-84.1% YoY), -$47.0M in net income, and -$29.8M in free cash flow against $24.7M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is CODX trading relative to its 50-day, 200-day, and 52-week technical levels?
CODX last traded at $0.40 (-10.49% on volume of 553,918 shares), positioning the stock -59.18% below its 50-day simple moving average ($0.98) and -81.82% below its 200-day simple moving average ($2.20). Across its 52-week range of $0.37 to $13.80, CODX sits at the 0.2% percentile with a 14-day RSI of 19.1 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.00 to $0.45).
CODX Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is CODX stock moving today?
Why CODX Stock dropped -10.49% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.